Genomic architecture characterizes tumor progression paths and fate in breast cancer patients. - Wikidata - awgldk - TriplyDB

Genomic architecture characterizes tumor progression paths and fate in breast cancer patients.

Genomic architecture characterizes tumor progression paths and fate in breast cancer patients.

http://www.wikidata.org/entity/Q37678826

about

ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium Emerging Role of Genomic Rearrangements in Breast Cancer: Applying Knowledge from Other Cancers Cancer classification in the genomic era: five contemporary problems Genomic profiling of breast cancers The potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signalling The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes Integrated analysis of high-resolution DNA methylation profiles, gene expression, germline genotypes and clinical end points in breast cancer patients A systematic comparison of copy number alterations in four types of female cancer Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation 'Omic approaches to preventing or managing metastatic breast cancer The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.Genome-wide copy number analysis of single cells.Copynumber: Efficient algorithms for single- and multi-track copy number segmentation.Identifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression data The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells - A data description Nuclear CSPP1 expression defined subtypes of basal-like breast cancer.COLT-Cancer: functional genetic screening resource for essential genes in human cancer cell lines.The breast cancer genome--a key for better oncology What are we learning from the cancer genome?Long non-coding RNAs differentially expressed between normal versus primary breast tumor tissues disclose converse changes to breast cancer-related protein-coding genes.Characterization of microfluidic shear-dependent epithelial cell adhesion molecule immunocapture and enrichment of pancreatic cancer cells from blood cells with dielectrophoresis.Systems consequences of amplicon formation in human breast cancer Simultaneous copy number gains of NUPR1 and ERBB2 predicting poor prognosis in early-stage breast cancer.An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosis Structural analysis of the genome of breast cancer cell line ZR-75-30 identifies twelve expressed fusion genes.Micro-scale genomic DNA copy number aberrations as another means of mutagenesis in breast cancer.High levels of genomic aberrations in serous ovarian cancers are associated with better survival.Systems biology and genomics of breast cancer.Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients.A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer Genome aberrations in canine mammary carcinomas and their detection in cell-free plasma DNA.Genomic instability: a stronger prognostic marker than proliferation for early stage luminal breast carcinomas.Enhancing sensitivity and specificity in rare cell capture microdevices with dielectrophoresis.Characterization of genomic alterations in radiation-associated breast cancer among childhood cancer survivors, using comparative genomic hybridization (CGH) arrays.Quantitative multigene FISH on breast carcinomas identifies der(1;16)(q10;p10) as an early event in luminal A tumors Chromosome-breakage genomic instability and chromothripsis in breast cancer Insight into the heterogeneity of breast cancer through next-generation sequencing.A new tumor biomarker, serum protein peak at 3,144 m/z, in patients with node-positive breast cancer.Optimizing sparse sequencing of single cells for highly multiplex copy number profiling

P2860

Q24293658-83F33C7E-FC34-4CF9-894D-AD2F0AE6D354 Q26766271-E871C83A-7F28-4398-B859-AAE1D8877E44 Q26781783-BA1323B1-B1EA-4B7A-8FFE-158427DB03F7 Q27013013-69FCD1A1-FC16-4DC6-89FA-45DAD915B59F Q28087571-B014D32E-8E60-488D-82CB-5E14ACE3D2EE Q28275430-E2CBF4FE-1F14-4B25-B041-75DD69CA125A Q28305345-41104880-D1B4-4BCA-9BFC-4313791C2677 Q28394747-9F574647-FE5F-4AC0-B6BD-3B29D7AFD01E Q28730029-A8E9A185-3673-4A9C-BCBC-734EE982309F Q28730572-9C380395-6805-446E-A469-1541450387E6 Q29614700-AA35C513-A13A-4D37-B030-B47F66047BAD Q30245184-7F5ECC9E-0D48-4C0B-8F46-AC5FAA486149 Q30372139-5FB4F793-5B88-4DBB-B593-5BA56FD0AE82 Q30536665-FDCD10FC-2209-4843-B4C0-598B538A63A5 Q30587051-2C085F45-B925-4595-925A-BD9A32B519E4 Q31008419-C608BAA3-D7A1-4F8E-AB69-C8D73F488866 Q33918128-A1666261-4A7D-46E8-BADB-717856E8F38E Q34079092-DB0EC74E-F015-4697-97EE-C7860E7D97C2 Q34086632-73CD7868-2BEA-4445-B8D3-82320B64817D Q34213994-A91D94E5-CF92-4FBC-870A-BC424EA78B79 Q34267035-61E6B5FD-BF33-4E89-8587-FB096C73A203 Q34304356-BF1F9A96-194A-4C81-894D-F0577D751096 Q34350077-7E1C2C3B-152E-44F4-9EFF-6B7EB45A057E Q34400615-2FC0699C-48A8-4245-969C-9F597DA5BB8A Q34491930-E8321A12-8BCD-4B0B-8B05-6AD99CE1BFD9 Q34520381-9B277FA2-3FD4-4990-A577-9D47C619A450 Q34532230-2F5FABCD-3B14-452A-87F2-A6DCDC53F9D9 Q34571142-1EA9294D-8A62-4F68-A35A-193E50B5747E Q34576377-081E51DB-6264-4BF6-9881-0D4F38119BD2 Q34621219-6639A444-7687-4AE7-9246-A3A42478590A Q34854883-4BBF33A6-D74E-4296-8242-17676D58A943 Q35010017-4307AC5C-520D-43FB-A50F-A6A0A30774E2 Q35021646-FFF091F5-7751-459D-A8A7-4599E1803711 Q35082937-E18A81B7-7CAC-4DDC-8CD9-F501B2DD3F79 Q35170898-27C7A66B-DA43-491F-95C7-29DBDF44C5D6 Q35204472-03712ACF-D1FD-48A6-93AA-47093E8C369A Q35204806-22D90EA9-A5B8-4322-A2F9-878142DB6E9B Q35370090-22A318D7-4493-4EBF-90B4-DE83A3A3568D Q35523088-1FB8A465-5F8C-42AC-AD6A-771B48D10349 Q35561968-E5559D3A-569E-4704-AC34-1C9B895EE52C

P2860

Genomic architecture characterizes tumor progression paths and fate in breast cancer patients.

http://www.wikidata.org/entity/Q37678826

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Genomic architecture character ...... ate in breast cancer patients.

@en

Genomic architecture character ...... ate in breast cancer patients.

@nl

type

label

Genomic architecture character ...... ate in breast cancer patients.

@en

Genomic architecture character ...... ate in breast cancer patients.

@nl

prefLabel

Genomic architecture character ...... ate in breast cancer patients.

@en

Genomic architecture character ...... ate in breast cancer patients.

@nl

P1433

Q37678826-368254B8-0B12-4BD2-9F11-8AAE0D41F7DA

P1476

Q37678826-8C19E260-B624-46F4-A426-E52236B7F37A

P2093

Q37678826-1FFB5BA7-64B0-4C7A-978A-8DC835FF4F40

Q37678826-43B4DC8D-ABFB-40E7-84C4-F28563A5C33F

Q37678826-67F0036A-D162-448D-8EF1-6A39C15CF800

Q37678826-6F74234F-BCD1-4B0D-9587-8D12BEAC9467

Q37678826-7A1FC7DE-A156-40C8-9345-82E3C6A6423B

Q37678826-840BF6C3-970C-4CCD-9671-78032F6DE2EE

Q37678826-8D49EAB5-33EC-467A-B64F-8B4DC4D4A912

Q37678826-91D3E30C-BA89-4C8F-AE67-BF8267A505B7

Q37678826-AD8B61E0-9877-42B5-A958-C91AE0C09FB7

Q37678826-C9C270DF-D2DD-4B64-B33E-C8435527A42B

P2860

Q37678826-04C8E13D-A9A2-4288-9E7C-824259BFF31D

Q37678826-094EB77D-F7BF-4EF7-9EAD-F83C57B8CBA1

Q37678826-0E77BD19-C941-4421-8BA1-656C715AC0A7

Q37678826-1977C0C8-2869-4DED-B995-B4A78A7BAA27

Q37678826-1B95C29E-AA72-4B3E-8510-0C2BAE686B0C

Q37678826-22279CC7-2370-4507-9A92-BC2F6F909C74

Q37678826-24FFA747-8732-415A-BD95-D209615120FB

Q37678826-26B2378D-9B88-40C3-8788-1A90D326B4C8

Q37678826-27523A23-CA6E-4ABC-BA83-050BDF7AC260

Q37678826-2864A0EE-6408-49D3-B145-A03EEEA70ADF

P304

Q37678826-A7497EC8-B192-49C2-B620-03E753550ABE

P31

Q37678826-569BF9EC-2256-4F34-9F5F-F26EA136793F

P356

Q37678826-F5D919DF-1B15-465E-AD74-820F08029033

P407

Q37678826-FCFF8A04-7F1E-4D6E-BABC-E334470EAF49

P433

Q37678826-0BD54F5A-333A-4442-A99C-23D3D6A143FB

P478

Q37678826-416101F4-C2BA-4589-84A5-860F887A895A

P50

Q37678826-08766646-6EF8-4988-BDB7-8DD2B12AF2F9

Q37678826-0FBA36CE-2C3C-41FE-BC55-DE242D41A52A

Q37678826-1A6233BB-A22F-423E-A01B-20001F2218CE

Q37678826-3D457FBC-D9F0-4A83-B474-499ECEC886CA

Q37678826-45808BE8-ECD2-4F1B-8706-9F2ED23ED1D8

Q37678826-76A3C6D4-DBA0-4604-BA4D-546C31E416FE

Q37678826-8A4F3EF4-06E5-4DCE-9296-194BBC2C5944

Q37678826-AD00AD97-4710-4EE1-800D-766DB2E3EE67

Q37678826-AED6D186-1949-44E8-BC03-6993F6693176

Q37678826-B385E2AA-5C21-47CC-9E55-19565438FCEA

P577

Q37678826-E2778459-0E37-4896-850C-5A45CC099C1C

P698

Q37678826-018E5194-A347-4C03-803C-57E954CDAE88

P921

Q37678826-0534F3BF-5548-4B94-AEF7-0DAECA2E53DF

P932

Q37678826-31C28041-8C74-487C-BA52-A35F04B7B8BD

P356

SCITRANSLMED.3000611

P1433

Science Translational Medicine

P1476

Genomic architecture character ...... ate in breast cancer patients.

@en

P2093

Alexander Krasnitz

http://www.w3.org/2001/XMLSchema#string

Anders Zetterberg

http://www.w3.org/2001/XMLSchema#string

Andrew E Teschendorff

http://www.w3.org/2001/XMLSchema#string

Ellen Schlichting

http://www.w3.org/2001/XMLSchema#string

Inga H Rye

http://www.w3.org/2001/XMLSchema#string

James Hicks

http://www.w3.org/2001/XMLSchema#string

Michael P Stratton

http://www.w3.org/2001/XMLSchema#string

Philip J Stephens

http://www.w3.org/2001/XMLSchema#string

Pär Lundin

http://www.w3.org/2001/XMLSchema#string

Susanne Månér

http://www.w3.org/2001/XMLSchema#string

P2860

Bioconductor: open software development for computational biology and bioinformatics

The Stability of Broken Ends of Chromosomes in Zea Mays.

Complex landscapes of somatic rearrangement in human breast cancer genomes.

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

Gene expression profiling identifies activated growth factor signaling in poor prognosis (Luminal-B) estrogen receptor positive breast cancer

Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing

Human and mouse oligonucleotide-based array CGH.

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Molecular portraits of human breast tumours

Repeated observation of breast tumor subtypes in independent gene expression data sets

P304

38ra47

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCITRANSLMED.3000611

http://www.w3.org/2001/XMLSchema#string

P407

P433

38

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Anne-Lise Børresen-Dale

Hans Kristian Moen Vollan

Suet-feung Chin

Ole Christian Lingjærde

Therese Sørlie

Lars O. Baumbusch

Anita Langerød

Hege G. Russnes

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20592421

http://www.w3.org/2001/XMLSchema#string

P921

P932

3972440

http://www.w3.org/2001/XMLSchema#string